![](/img/cover-not-exists.png)
P0771 : C-SCAPE: Efficacy and safety of 12 weeks of grazoprevir +/- elbasvir +/- ribavirin in patients with HCV GT2, 4, 5 or 6 infection
Brown, A., Hezode, C., Zuckerman, E., Foster, G., Zekry, A., Roberts, S., Howe, A., Durkan, C., Badshah, C., Zhang, B., Robertson, M., Wahl, J., Barr, E., Haber, B.Volume:
62
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(15)30974-0
Date:
April, 2015
File:
PDF, 94 KB
english, 2015